关注
Pui San Tan
Pui San Tan
在 nottingham.edu.my 的电子邮件经过验证
标题
引用次数
引用次数
年份
The challenge of antimicrobial resistance: what economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), eaau4679, 2019
4142019
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
J Hippisley-Cox, D Young, C Coupland, KM Channon, P San Tan, ...
Heart 106 (19), 1503-1511, 2020
3832020
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
P Aveyard, M Gao, N Lindson, J Hartmann-Boyce, P Watkinson, D Young, ...
The lancet Respiratory medicine 9 (8), 909-923, 2021
2472021
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.
CBDM SK Tonkin-Crine, PS Tan, O van Hecke, K Wang, NW Roberts, A McCullough ...
The Cochrane database of systematic reviews 9, CD012252, 2017
2222017
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
AK Clift, A Von Ende, P San Tan, HM Sallis, N Lindson, CAC Coupland, ...
Thorax 77 (1), 65-73, 2022
1732022
Ten-year survival in women with primary stage IV breast cancer
LG Eng, S Dawood, V Sopik, B Haaland, PS Tan, N Bhoo-Pathy, ...
Breast cancer research and treatment 160, 145-152, 2016
1242016
Cost-effectiveness of Osimertinib in the first-line treatment of patients with EGFR-Mutated advanced non–Small cell lung Cancer
PN Aguiar, B Haaland, W Park, P San Tan, A del Giglio, G de Lima Lopes
JAMA oncology 4 (8), 1080-1084, 2018
1162018
Meta-analysis of first-line therapies in advanced non–small-cell lung cancer harboring EGFR-activating mutations
B Haaland, P San Tan, G de Castro Jr, G Lopes
Journal of Thoracic Oncology 9 (6), 805, 2014
1132014
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B. 1.1. 7 in England: an observational cohort study
M Patone, K Thomas, R Hatch, P San Tan, C Coupland, W Liao, ...
The Lancet Infectious Diseases 21 (11), 1518-1528, 2021
1032021
Association between race and COVID-19 outcomes among 2.6 million children in England
D Saatci, TA Ranger, C Garriga, AK Clift, F Zaccardi, P San Tan, M Patone, ...
JAMA pediatrics 175 (9), 928-938, 2021
972021
Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis
JY Verbakel, JJ Lee, C Goyder, P San Tan, T Ananthakumar, PJ Turner, ...
BMJ open 9 (1), e025036, 2019
732019
Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer–A systematic review and network meta-analysis of 3024 …
P San Tan, P Aguiar Jr, B Haaland, G Lopes
Lung Cancer 115, 84-88, 2018
552018
The clinical utility of point-of-care tests for influenza in ambulatory care: A systematic review and meta-analysis
JJ Lee, JY Verbakel, CR Goyder, T Ananthakumar, PS Tan, PJ Turner, ...
Clinical Infectious Diseases 69 (1), 24-33, 2019
482019
Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases
M Patone, K Thomas, R Hatch, PS Tan, C Coupland, W Liao, P Mouncey, ...
MedRxiv, 2021.03. 11.21253364, 2021
372021
A systematic review and meta-analyses of the association between anti-hypertensive classes and the risk of falls among older adults
HT Ang, KK Lim, YH Kwan, PS Tan, KZ Yap, Z Banu, CS Tan, W Fong, ...
Drugs & aging 35, 625-635, 2018
362018
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care
IJ Onakpoya, AS Walker, PS Tan, EA Spencer, OA Gbinigie, J Cook, ...
PloS one 13 (3), e0194858, 2018
362018
Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a …
PS Tan, P Aguiar, B Haaland, G Lopes
Prostate cancer and prostatic diseases 21 (4), 516-523, 2018
352018
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study
AK Clift, D Saatci, CAC Coupland, H Dambha-Miller, J Hippisley-Cox
Annals of Internal Medicine 174 (9), 1483-1487, 2021
342021
Meta‐analysis of first‐line therapies with maintenance regimens for advanced non‐small‐cell lung cancer (NSCLC) in molecularly and clinically selected populations
PS Tan, M Bilger, G de Lima Lopes, S Acharyya, B Haaland
Cancer medicine 6 (8), 1847-1860, 2017
282017
Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison
PS Tan, B Haaland, AJ Montero, CE Kyriakopoulos, G Lopes
Clinical Medicine Insights: Oncology 8, CMO. S13671, 2014
272014
系统目前无法执行此操作,请稍后再试。
文章 1–20